These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32404686)

  • 1. Up to a Quarter of Children With Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis With Varicella Immunoglobulin: A Single Center UK Experience Over 3 Years.
    Prince NJ; Taj M; Bate JM
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):36-37. PubMed ID: 32404686
    [No Abstract]   [Full Text] [Related]  

  • 2. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
    Bate J; Baker S; Breuer J; Chisholm JC; Gray J; Hambleton S; Houlton A; Jit M; Lowis S; Makin G; O'Sullivan C; Patel SR; Phillips R; Ransinghe N; Ramsay ME; Skinner R; Wheatley K; Heath PT
    Arch Dis Child; 2019 Jan; 104(1):25-29. PubMed ID: 29730641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of varicella vaccine as post exposure prophylaxis in Chilean children].
    Pinochet C; Cerda J; Hirsch T; Mieres J; Inostroza C; Abarca K
    Rev Chilena Infectol; 2012 Dec; 29(6):635-40. PubMed ID: 23412032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; Heywood A; McIntyre P
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001833. PubMed ID: 24954057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus epidemiology--a changing scene?
    Fairley CK; Miller E
    J Infect Dis; 1996 Nov; 174 Suppl 3():S314-9. PubMed ID: 8896538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Revised multidisciplinary guidelines 'Varicella'; broader indication for post-exposure prophylaxis].
    van Kampen JJA; Bruns AHW; van Leeuwen E; Koelewijn JM; Ruijs WLM; Komen DJC; Vermont CL; Opstelten W
    Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32779924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong.
    Chui KS; Wu HL; You JH
    Scand J Infect Dis; 2014 Jan; 46(1):27-33. PubMed ID: 24228821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children with breakthrough varicella infection requiring hospitalization in Turkey (VARICOMP Study 2008-2013).
    Dinleyici EC; Kurugol Z; Kara A; Tezer H; Tas MA; Guler E; Yasa O; Devrim I; Ciftci E; Ozdemir H; Somer A; Ozen M; Sensoy G; Dalgic N; Alhan E;
    Vaccine; 2015 Jul; 33(32):3983-7. PubMed ID: 26133048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
    McKendrick MW; Lau J; Alston S; Bremner J
    J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella outbreak trends in school settings during the voluntary single-dose vaccine era from 2006 to 2017 in Shanghai, China.
    Wu QS; Wang X; Liu JY; Chen YF; Zhou Q; Wang Y; Sha JD; Xuan ZL; Zhang LW; Yan L; Hu Y
    Int J Infect Dis; 2019 Dec; 89():72-78. PubMed ID: 31521857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
    Gans H; Chemaly RF
    BMC Infect Dis; 2021 Jan; 21(1):46. PubMed ID: 33430796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia.
    Gidding HF; Brisson M; Macintyre CR; Burgess MA
    Aust N Z J Public Health; 2005 Dec; 29(6):544-51. PubMed ID: 16366065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
    Bate J; Chisholm J; Heath PT; Breuer J; Skinner R; Manley S; Patel S; Wheatley K; Ramsay M; Kearns PR; Hambleton S
    Arch Dis Child; 2011 Sep; 96(9):841-5. PubMed ID: 21715391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing varicella in children with malignancies: what is the evidence?
    Fisher JP; Bate J; Hambleton S
    Curr Opin Infect Dis; 2011 Jun; 24(3):203-11. PubMed ID: 21455062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.
    Ogilvie MM
    J Infect; 1998 Jan; 36 Suppl 1():31-8. PubMed ID: 9514106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the burden of varicella in UK general practice.
    Walker JL; Andrews NJ; Mathur R; Smeeth L; Thomas SL
    Epidemiol Infect; 2017 Oct; 145(13):2678-2682. PubMed ID: 28853391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anti-chickenpox immunoglobulin in the prevention of chickenpox.
    Evans EB; Pollock TM; Cradock-Watson JE; Ridehalgh MK
    Lancet; 1980 Feb; 1(8164):354-6. PubMed ID: 6101802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of varicella vaccines as postexposure prophylaxis.
    Brotons M; Campins M; Méndez L; Juste C; Rodrigo JA; Martínez X; Hermosilla E; Pinós L; Vaqué J
    Pediatr Infect Dis J; 2010 Jan; 29(1):10-3. PubMed ID: 19841607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella post-exposure management for pediatric oncology patients.
    Costa G; Orbach D; Saulpic J; Sarda-Thibault H; Hanslik T; Brethon B; Tabone MD; Raimbault S; Papillard S; Guillaumat C; Nathanson S; Pellegrino B; Belloy M; Mesples B; Trioche P; Jaber H; Raimondo G; Gilet C; Cohen-Gogo S
    Bull Cancer; 2022 Mar; 109(3):287-295. PubMed ID: 35093244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.